KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Assets (2016 - 2025)

Historic Current Assets for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $382.5 million.

  • Neogenomics' Current Assets fell 3520.19% to $382.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $382.5 million, marking a year-over-year decrease of 3520.19%. This contributed to the annual value of $596.0 million for FY2024, which is 13.29% down from last year.
  • Neogenomics' Current Assets amounted to $382.5 million in Q3 2025, which was down 3520.19% from $392.6 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Current Assets peaked at $942.7 million during Q1 2021, and registered a low of $382.5 million during Q3 2025.
  • Moreover, its 5-year median value for Current Assets was $596.0 million (2024), whereas its average is $609.7 million.
  • As far as peak fluctuations go, Neogenomics' Current Assets soared by 33758.04% in 2021, and later plummeted by 3520.19% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Current Assets stood at $681.5 million in 2021, then fell by 11.18% to $605.3 million in 2022, then decreased by 1.4% to $596.8 million in 2023, then decreased by 0.13% to $596.0 million in 2024, then crashed by 35.83% to $382.5 million in 2025.
  • Its Current Assets stands at $382.5 million for Q3 2025, versus $392.6 million for Q2 2025 and $573.9 million for Q1 2025.